Position in RPRX
as of Mar 31, 2026
· filed Jun 15, 2026
Position Value
$30,278,664
New position
Shares Held
631,200
first reported quarter
Ownership
0.110%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Carmignac Gestion holds $218,566,713 across 10 Biotechnology names. RPRX ranks #3 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
116,571 | $90,067,417 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
148,199 | $66,176,781 | |
| 3 | RPRX |
Royalty Pharma plc
This page
|
631,200 | $30,278,664 | |
| 4 | FOLD |
AMICUS THERAPEUTICS, INC.
|
784,508 | $11,343,985 | |
| 5 | BNTX |
BioNTech SE
|
112,711 | $10,017,753 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
53,000 | $3,979,770 | |
| 7 | TERN |
Terns Pharmaceuticals, Inc.
|
53,541 | $2,822,681 | |
| 8 | ACLX |
Arcellx, Inc.
|
18,925 | $2,172,968 |
All Filings in RPRX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $30,278,664 | 631,200 | Shares | Sole | 2026-06-15 | |
| No filing history on record for this holder in this stock. | ||||||